HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haraguchi, K. Articles by Chiba, S. Search for Related Content PubMed PubMed Citation Articles by Haraguchi, K. Articles by Chiba, S. Pubmed/NCBI databases Gene Compound via MeSH Substance via MeSH Medline Plus Health Information Bone Marrow Transplantation

Host-Residual Invariant NK T Cells Attenuate Graft-versus-Host Immunity¹

Kyoko Haraguchi^*,, Tsuyoshi Takahashi^*,2, Akihiko Matsumoto^*,, Takashi Asai^*, Yoshinobu Kanda^*,, Mineo Kurokawa^*, Seishi Ogawa^*,, Hideaki Oda, Masaru Taniguchi^¶, Hisamaru Hirai^3,*, and Shigeru Chiba^4,*,

Departments of^* Hematology/Oncology, Cell Therapy/Transplantation Medicine, and Regeneration Medicine for Hematopoiesis, University of Tokyo Graduate School of Medicine and Hospital, Tokyo, Japan; Department of Pathology, Tokyo Women’s Medical University, Tokyo, Japan; and ^¶ RIKEN Research Center for Allergy and Immunology, Yokohama, Japan

Invariant NK T (iNKT) cells have an invariant TCR- chain and are activated in a CD1d-restricted manner. They are thought to regulate immune responses and play important roles in autoimmunity, allergy, infection, and tumor immunity. They also appear to influence immunity after hemopoietic stem cell transplantation. In this study, we examined the role of iNKT cells in graft-vs-host disease (GVHD) and graft rejection in a mouse model of MHC-mismatched bone marrow transplantation, using materials including -galactosylceramide, NKT cells expanded in vitro, and J18 knockout mice that lack iNKT cells. We found that host-residual iNKT cells constitute effector cells which play a crucial role in reducing the severity of GVHD, and that this reduction is associated with a delayed increase in serum Th2 cytokine levels. Interestingly, we also found that host-residual iNKT cause a delay in engraftment and, under certain conditions, graft rejection. These results indicate that host-residual iNKT cells attenuate graft-vs-host immunity rather than host-vs-graft immunity.

This article has been cited by other articles:

				J. H. Kim, E. Y. Choi, and D. H. Chung Donor Bone Marrow Type II (Non-V{alpha}14J{alpha}18 CD1d-Restricted) NKT Cells Suppress Graft-Versus-Host Disease by Producing IFN-{gamma} and IL-4 J. Immunol., November 15, 2007; 179(10): 6579 - 6587. [Abstract] [Full Text] [PDF]

				M. N. Ajuebor, J. A. Carey, and M. G. Swain CCR5 in T Cell-Mediated Liver Diseases: What's Going On? J. Immunol., August 15, 2006; 177(4): 2039 - 2045. [Abstract] [Full Text] [PDF]

				E. S. Morris, K. P. A. MacDonald, and G. R. Hill Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL? Blood, May 1, 2006; 107(9): 3430 - 3435. [Abstract] [Full Text] [PDF]

				S. Patterson, I. Kotsianidis, A. Almeida, M. Politou, A. Rahemtulla, B. Matthew, R. R. Schmidt, V. Cerundolo, I. A. G. Roberts, and A. Karadimitris Human Invariant NKT Cells Are Required for Effective In Vitro Alloresponses J. Immunol., October 15, 2005; 175(8): 5087 - 5094. [Abstract] [Full Text] [PDF]